FDA clears Apple’s sleep apnea detection feature for use

FDA clears Apple’s sleep apnea detection feature for use

Tim Cook, chief executive officer of Apple Inc., during an event at Apple Park campus in Cupertino, California, US, on Monday, Sept. 9, 2024. Apple Inc. unveiled a new version of its smartwatch with a bigger screen and the ability to detect sleep apnea, part of an event Monday that will also include the iPhone … Read more

Radiopharmaceuticals race heats up as drugmakers chase Novartis

Radiopharmaceuticals race heats up as drugmakers chase Novartis

Drugmakers are betting that delivering radiation directly to tumors will become the next big cancer breakthrough.  Bristol Myers Squibb, AstraZeneca, Eli Lilly and other pharmaceutical companies have spent some $10 billion on deals to acquire or work with radiopharmaceuticals makers. They’ve snapped up smaller upstarts to get their hands on technology that, while in its … Read more

Senate committee to vote to hold Steward Health Care CEO in contempt

Senate committee to vote to hold Steward Health Care CEO in contempt

BOSTON — Members of a Senate committee looking into the Steward Health Care bankruptcy said they plan to adopt two resolutions next week to hold Steward CEO Ralph de la Torre in contempt — one for civil enforcement and another for certification to the United States Attorney for criminal contempt — after he refused to … Read more

Pfizer’s cancer cachexia drug shows positive midstage trial results

Pfizer’s cancer cachexia drug shows positive midstage trial results

Pfizer‘s experimental drug for a common, life-threatening condition that causes cancer patients to lose their appetite and weight showed positive results in a midstage trial, the drugmaker said Saturday.  Patients with the condition, called cancer cachexia, who took Pfizer’s treatment saw improvements in body weight, muscle mass, quality of life and physical function, according to … Read more

Gilead Lenacapavir cut HIV infections by 96% in trial

Gilead Lenacapavir cut HIV infections by 96% in trial

A pharmacist holds a vial of lenacapavir, the new HIV prevention injectable drug. Nardus Engelbrecht | AP Gilead‘s twice-yearly shot reduced HIV infections by 96% in a second large study, the company said Thursday. The positive phase three trial data on lenacapavir sets the stage for likely approval by the U.S. Food and Drug Administration … Read more

Noom to offer GLP-1 drug through new weight loss program

Noom to offer GLP-1 drug through new weight loss program

Digital health company Noom on Thursday announced it will offer a compounded GLP-1 drug as part of a new weight loss product that starts at $149.  The treatment will feature compounded semaglutide, the same active ingredient in Novo Nordisk’s blockbuster obesity and diabetes drugs Wegovy and Ozempic. Noom has offered weight loss programs for years, … Read more

Apple turns AirPods into hearing aids, focusing on big health market

Apple turns AirPods into hearing aids, focusing on big health market

Soon, people with AirPods in their ears might not be drowning you out — they might be wearing them to hear you better. Apple announced on Monday that its AirPods Pro 2 headphones will become an FDA-cleared hearing aid in the coming weeks through a software update. That means that adults with mild or moderate … Read more

Eli Lilly to boost output of weight loss, diabetes, Alzheimer’s drugs

Eli Lilly to boost output of weight loss, diabetes, Alzheimer’s drugs

A sign with the company logo sits outside of the headquarters of Eli Lilly in Indianapolis, Indiana, on March 17, 2024. Scott Olson | Getty Images Eli Lilly on Thursday said it will invest $1.8 billion to boost manufacturing for its newly approved Alzheimer’s drug and highly popular weight loss and diabetes treatments, among other medicines, … Read more

$1 billion in cost cuts, 10 product launches planned

 billion in cost cuts, 10 product launches planned

Moderna headquarters, exterior view, Cambridge, Massachusetts, USA.  Plexi Images | GHI | UCG | Universal Images Group | Getty Images Moderna on Thursday said it plans to cut around $1.1 billion in expenses by 2027 and win approvals for several new products as it charts a path forward after the rapid decline of its Covid business.  … Read more

How a traveling ‘health train’ has become an essential source of free care in South Africa

How a traveling ‘health train’ has become an essential source of free care in South Africa

JOHANNESBURG — Thethiwe Mahlangu woke early on a chilly morning and walked through her busy South African township, where minibuses hooted to pick up commuters and smoke from sidewalk breakfast stalls hung in the air. Her eyes had been troubling her. But instead of going to her nearby health clinic, Mahlangu was headed to the … Read more